Compare RGNX & TMQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGNX | TMQ |
|---|---|---|
| Founded | 2008 | 2004 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 418.1M | 700.5M |
| IPO Year | 2015 | 2012 |
| Metric | RGNX | TMQ |
|---|---|---|
| Price | $9.30 | $4.15 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $28.75 | N/A |
| AVG Volume (30 Days) | 570.9K | ★ 2.4M |
| Earning Date | 05-11-2026 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,393,000.00 | N/A |
| Revenue This Year | $50.15 | N/A |
| Revenue Next Year | $23.42 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 126.48 | N/A |
| 52 Week Low | $5.85 | $1.17 |
| 52 Week High | $16.19 | $11.29 |
| Indicator | RGNX | TMQ |
|---|---|---|
| Relative Strength Index (RSI) | 57.11 | 57.06 |
| Support Level | $7.76 | $3.30 |
| Resistance Level | $10.08 | $4.46 |
| Average True Range (ATR) | 0.51 | 0.24 |
| MACD | 0.16 | 0.10 |
| Stochastic Oscillator | 95.65 | 84.37 |
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the USA. Its properties include the Arctic copper-zinc-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.